<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Entropy Neurodynamics Limited — News on 6ix</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited</link>
<description>Latest news and press releases for Entropy Neurodynamics Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 03:50:04 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/entropy-neurodynamics-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d5a8d7beedb30cb6f9969f.webp</url>
<title>Entropy Neurodynamics Limited</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited</link>
</image>
<item>
<title>TRP-8803 delivers repeatable, high-intensity effect</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/trp-8803-delivers-repeatable-high-intensity-effect</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/trp-8803-delivers-repeatable-high-intensity-effect</guid>
<pubDate>Tue, 14 Apr 2026 03:50:04 GMT</pubDate>
<description>TRP-8803 delivers repeatable, high-intensity effect</description>
</item>
<item>
<title>FY25 R&D Tax Incentive received</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/fy25-randd-tax-incentive-received</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/fy25-randd-tax-incentive-received</guid>
<pubDate>Thu, 05 Mar 2026 04:06:05 GMT</pubDate>
<description>FY25 R&D Tax Incentive received</description>
</item>
<item>
<title>Cohort 1 enrolment achieved for TRP-8803 BED Trial</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/cohort-1-enrolment-achieved-for-trp-8803-bed-trial</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/cohort-1-enrolment-achieved-for-trp-8803-bed-trial</guid>
<pubDate>Tue, 03 Mar 2026 03:19:15 GMT</pubDate>
<description>Cohort 1 enrolment achieved for TRP-8803 BED Trial</description>
</item>
<item>
<title>Appendix 4D and Half Year Report for period 31 Dec 2025</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/appendix-4d-and-half-year-report-for-period-31-dec-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/appendix-4d-and-half-year-report-for-period-31-dec-2025-1</guid>
<pubDate>Fri, 27 Feb 2026 03:33:13 GMT</pubDate>
<description>Appendix 4D and Half Year Report for period 31 Dec 2025</description>
</item>
<item>
<title>Australian Patent Secures TRP 8803 Platform to 2042</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/australian-patent-secures-trp-8803-platform-to-2042</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/australian-patent-secures-trp-8803-platform-to-2042</guid>
<pubDate>Thu, 12 Feb 2026 02:53:14 GMT</pubDate>
<description>Australian Patent Secures TRP 8803 Platform to 2042</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/quarterly-activities-report-and-appendix-4c-79</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/quarterly-activities-report-and-appendix-4c-79</guid>
<pubDate>Fri, 30 Jan 2026 03:18:21 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C</description>
</item>
<item>
<title>First TRP-8803 BED patient shows broad clinical improvement</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/first-trp-8803-bed-patient-shows-broad-clinical-improvement</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/first-trp-8803-bed-patient-shows-broad-clinical-improvement</guid>
<pubDate>Thu, 22 Jan 2026 02:53:12 GMT</pubDate>
<description>First TRP-8803 BED patient shows broad clinical improvement</description>
</item>
<item>
<title>TRP-8802 Phase 2a Trial Shows Sustained BED Reduction</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/trp-8802-phase-2a-trial-shows-sustained-bed-reduction</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/trp-8802-phase-2a-trial-shows-sustained-bed-reduction</guid>
<pubDate>Tue, 13 Jan 2026 02:44:16 GMT</pubDate>
<description>TRP-8802 Phase 2a Trial Shows Sustained BED Reduction</description>
</item>
<item>
<title>$847,186 R&D Tax Incentive received</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/dollar847186-randd-tax-incentive-received</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/dollar847186-randd-tax-incentive-received</guid>
<pubDate>Fri, 19 Dec 2025 03:35:21 GMT</pubDate>
<description>$847,186 R&D Tax Incentive received</description>
</item>
<item>
<title>First BED patient completes second TRP-8803 infusion</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/first-bed-patient-completes-second-trp-8803-infusion</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/first-bed-patient-completes-second-trp-8803-infusion</guid>
<pubDate>Tue, 16 Dec 2025 03:05:09 GMT</pubDate>
<description>First BED patient completes second TRP-8803 infusion</description>
</item>
<item>
<title>First patient successfully dosed in TRP 8803 BED trial</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/first-patient-successfully-dosed-in-trp-8803-bed-trial</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/first-patient-successfully-dosed-in-trp-8803-bed-trial</guid>
<pubDate>Tue, 02 Dec 2025 03:30:14 GMT</pubDate>
<description>First patient successfully dosed in TRP 8803 BED trial</description>
</item>
<item>
<title>BED trial accelerates - enrolment grows, dosing in two weeks</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/bed-trial-accelerates-enrolment-grows-dosing-in-two-weeks</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/bed-trial-accelerates-enrolment-grows-dosing-in-two-weeks</guid>
<pubDate>Tue, 18 Nov 2025 03:16:05 GMT</pubDate>
<description>BED trial accelerates - enrolment grows, dosing in two weeks</description>
</item>
<item>
<title>$6.1m in new funding to accelerate clinical development</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/dollar61m-in-new-funding-to-accelerate-clinical-development</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/dollar61m-in-new-funding-to-accelerate-clinical-development</guid>
<pubDate>Wed, 05 Nov 2025 03:58:11 GMT</pubDate>
<description>$6.1m in new funding to accelerate clinical development</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/trading-halt-1476</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/trading-halt-1476</guid>
<pubDate>Mon, 03 Nov 2025 03:43:12 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>First patient enrolled in Binge Eating Disorder Trial</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/first-patient-enrolled-in-binge-eating-disorder-trial</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/first-patient-enrolled-in-binge-eating-disorder-trial</guid>
<pubDate>Tue, 14 Oct 2025 02:34:17 GMT</pubDate>
<description>First patient enrolled in Binge Eating Disorder Trial</description>
</item>
<item>
<title>Appendix 4E and 2025 Annual Report</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/appendix-4e-and-2025-annual-report-55</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/appendix-4e-and-2025-annual-report-55</guid>
<pubDate>Fri, 29 Aug 2025 03:12:37 GMT</pubDate>
<description>Appendix 4E and 2025 Annual Report</description>
</item>
<item>
<title>Landmark EEG Biomarker Agreement for Precision Psychiatry</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/landmark-eeg-biomarker-agreement-for-precision-psychiatry</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/landmark-eeg-biomarker-agreement-for-precision-psychiatry</guid>
<pubDate>Thu, 21 Aug 2025 03:18:33 GMT</pubDate>
<description>Landmark EEG Biomarker Agreement for Precision Psychiatry</description>
</item>
<item>
<title>$2.6m in non-dilutive capital funding secured</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/dollar26m-in-non-dilutive-capital-funding-secured</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/dollar26m-in-non-dilutive-capital-funding-secured</guid>
<pubDate>Tue, 12 Aug 2025 02:49:16 GMT</pubDate>
<description>$2.6m in non-dilutive capital funding secured</description>
</item>
<item>
<title>Patient recruitment for world first TRP-8803 trial underway</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/patient-recruitment-for-world-first-trp-8803-trial-underway</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/patient-recruitment-for-world-first-trp-8803-trial-underway</guid>
<pubDate>Mon, 21 Jul 2025 02:47:27 GMT</pubDate>
<description>Patient recruitment for world first TRP-8803 trial underway</description>
</item>
<item>
<title>Binge Eating Disorder Trial receives Human Ethics approval</title>
<link>https://6ix.com/company/entropy-neurodynamics-limited/news/binge-eating-disorder-trial-receives-human-ethics-approval</link>
<guid isPermaLink="true">https://6ix.com/company/entropy-neurodynamics-limited/news/binge-eating-disorder-trial-receives-human-ethics-approval</guid>
<pubDate>Mon, 23 Jun 2025 03:54:18 GMT</pubDate>
<description>Binge Eating Disorder Trial receives Human Ethics approval</description>
</item>
</channel>
</rss>